Method of diagnosing growth hormone disorders employing somatost

Details Method of diagnosing growth hormone disorders employing somatost Method of diagnosing growth hormone disorders employing somatost

1988-03-29

1989-07-04

Howell, Kyle L.

Surgery

Truss

Pad

128632, 424 9, A61B 500

Patent

active

048440965

ABSTRACT:
A diagnostic method whereby the sensitivity of inhibition of nocturnal growth hormone secretion by a growth hormone inhibiting factor is tested. The inhibiting factor or hormone, somatostatin is introduced into the bloodstream of sleeping children with classical GH deficiency, growth hormone neurosecretory dysfunction, and related disorders. The degree of suppression of the growth hormone secretion is studied to diagnose each child's condition preparatory to beginning a treatment program.

REFERENCES:
patent: 4410512 (1983-10-01), Bowers
patent: 4410513 (1983-10-01), Momann
patent: 4411890 (1983-10-01), Momann
Catt, An ABC of Endocrinology, Little Brown and Company, Boston, 1971, pp. 30-34.
Harrison's Principles of Internal Medicine, 10th Ed., McGraw-Hill, N.Y., 1983, pp. 597, 598 and 589.

Affiliated with

Also associated with

Rating

Method of diagnosing growth hormone disorders employing somatost does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing growth hormone disorders employing somatost, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing growth hormone disorders employing somatost will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-845329